Stockreport

Belite Bio to Participate in Three Upcoming Investor Conferences

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel t [Read more]